5 results on '"Yoon, Hyun Kyung"'
Search Results
2. Water extract of Cynanchi atrati Radix regulates inflammation and apoptotic cell death through suppression of IKK-mediated NF-κB signaling.
- Author
-
Jeon, Juhee, Park, Kyeong Ah, Lee, Hyunji, Shin, Sanghee, Zhang, Tiejun, Won, Minho, Yoon, Hyun Kyung, Choi, Min Kyung, Kim, Hyeong Geug, Son, Chang Gue, Hong, Jang Hee, and Hur, Gang Min
- Abstract
Abstract: Ethnopharmacological relevance: Cynanchi atrati Radix has been traditionally used as an anti-inflammatory agent to treat febrile diseases, acute urinary infection or subcutaneous pyogenic infection with invasion of the pathogenic factors. Aim of study: Nuclear factor (NF)-κB is a pleiotropic transcriptional factor of many genes involved in inflammatory and anti-apoptotic responses. To identify a novel, potent inhibitor of NF-κB signaling pathway, a plant extract library of traditional oriental medicine was screened for the capability to block the NF-κB activity in cells overexpressing toll-like receptor 4 (TLR4), and then evaluated the anti-inflammatory and pro-apoptotic functions of water extract of Cynanchi atrati Radix (WECR) in macrophages and cancer cells, respectively. Materials and methods: The effect of WECR on the proinflammatory mediators (inducible NO synthase [iNOS], cyclooxygenase [COX]-2), IκB-α degradation, RelA/p65 phosphorylation and caspase cleavages were measured by immunblotting. NF-κB transcriptional activity, IκB kinase (IKK) activity and nitric oxide (NO) production was measured using the luciferase assay, in vitro kinase assay and Griess reaction. Results: WECR efficiently inhibited LPS-induced expression of proinflammatory mediators including iNOS and COX-2. IKK kinase activity, IκB-α degradation, nuclear translocation of RelA/p65 and NF-κB transcriptional activity induced by LPS were suppressed by WECR. Furthermore, WECR dramatically enhances the apoptotic response, as evident by the combination with tumor necrosis factor (TNF) was able to induce the cytotoxic action through caspase-dependent pathway. Conclusion: These results indicate that WECR has a potential to inhibit IKK-mediated NF-κB activation, and is a valuable compound for modulating inflammatory or cancerous conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
3. Role of plasminogen activator inhibitor-2 (PAI-2) in keratinocyte differentiation
- Author
-
Jang, Sunhyae, Yang, Tae Ho, An, Eun Jeong, Yoon, Hyun Kyung, Sohn, Kyung-Cheol, Cho, Ah Young, Ryu, Eun-Kyoung, Park, Yeon-suk, Yoon, Tae Young, Lee, Jeung-Hoon, and Kim, Chang Deok
- Subjects
- *
ENZYME inhibitors , *PLASMINOGEN activators , *PHYSIOLOGICAL effects of calcium , *GENE expression , *MITOGEN-activated protein kinases , *REGULATION of cell growth ,KERATINOCYTE differentiation - Abstract
Abstract: Background: Plasminogen activator inhibitor-2 (PAI-2) is an enzyme inhibitor which is involved in various biological processes including cell differentiation, tissue regrowth and regeneration. Although PAI-2 has been originally isolated as an extracellular inhibitor of urokinase plasminogen activator (uPA), recent studies indicate that PAI-2 has other intracellular effects in keratinocyte, such as the component of cornified envelope. Objective: The aim of this study is to investigate the expression and functional role of PAI-2 during the keratinocyte differentiation. Methods: We transduced keratinocytes with adenovirus harboring the expression cassette for PAI-2, then examined the effect on keratinocytes differentiation. Results: When cultured epidermal keratinocytes were treated with 1.2mM calcium, PAI-2 expression was increased time-dependently at both mRNA and protein levels. The calcium-induced PAI-2 expression was abolished by treatment with p38 MAPK inhibitor, while overexpression of MKK6 led to the increase of PAI-2 expression. When PAI-2 was overexpressed by adenoviral transduction, the expression of keratinocyte differentiation markers such as involucrin, keratin 10 and loricrin was markedly increased. Concomitantly, overexpression of PAI-2 resulted in the retardation of cell growth, with the increase of Rb and p53. Conclusion: These results suggest that PAI-2 has a role for promoting the differentiation of epidermal keratinocytes. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
4. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells
- Author
-
Cho, Hee Jun, Kim, Jin Koo, Kim, Kwang Dong, Yoon, Hyun Kyung, Cho, Mi-Young, Park, Yuk Pheel, Jeon, Jun Ho, Lee, Eun Sik, Byun, Seok-Soo, Lim, Heon Man, Song, Eun Young, Lim, Jong-Seok, Yoon, Do-Young, Lee, Hee Gu, and Choe, Yong-Kyung
- Subjects
- *
DRUG therapy , *CANCER treatment , *APOPTOSIS , *CANCER cells - Abstract
Abstracts: The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance. To elucidate the molecular basis of resistance to cisplatin, we compared cisplatin-induced apoptotic responses of the parental human bladder cancer cell line, T24 and its resistant subclone, T24R2. In T24 cells, cisplatin induce apoptosis and the activation of caspase-8, -9 and -3 and poly(ADP-ribose) polymerase cleavage. The expression levels of Fas, FasL, and FADD were not changed by the treatment with cisplatin. Furthermore, neither Fas-neutralizing antibody nor dominant negative mutant of FADD affected cisplatin-induced apoptosis. Western blot analysis of subcellular fractions showed that cisplatin induced redistribution of Bax and cytochrome c. Thus, cisplatin causes apoptosis in a death receptor-independent and mitochondria-dependent fashion in T24 cells. In contrast, overexpressed Bcl-2 protein inhibited cisplatin-induced Bax translocation and its downstream events in T24R2. Downregulation of Bcl-2 by RNAi potentiated the redistribution of Bax and cytochrome c and reversed cisplatin-resistance. Our results indicate that upregulation of Bcl-2 contributes to the development of cisplatin-resistance and usage of siRNA which targets the Bcl-2 gene may offer a potential tool to reverse the resistance to cisplatin in bladder cancer. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
5. Up-regulation of Bfl-1/A1 via NF-κB activation in cisplatin-resistant human bladder cancer cell line
- Author
-
Kim, Jin Koo, Kim, Kwang Dong, Lee, Eunsik, Lim, Jong-Seok, Cho, Hee-Jun, Yoon, Hyun Kyung, Cho, Mi-Young, Baek, Kyoung-Eun, Park, Yuk Pheel, Paik, Sang-Gi, Choe, Yong-Kyung, and Lee, Hee Gu
- Subjects
- *
IRRADIATION , *CANCER , *DEATH , *GENES - Abstract
The potent anti-cancer agent cis-diamminedichloroplatinum (II) (cisplatin) is currently used for treating bladder cancer. However, clinical use of this drug for long periods is often limited because of the appearance of cisplatin-resistant bladder tumor cells. We employed the method of a differential display reverse transcriptase polymerase chain reaction to identify the differentially expressed genes in the parental human bladder cancer cell line, T24 and three cisplatin-resistant cell lines. We report here that cisplatin-resistant cell lines overexpress Bcl-2 family protein Bcl-2-related gene expressed in fetal liver (Bfl-1)/A1 as compared with their parental cell. Cisplatin and γ-irradiation induced expression of Bfl-1/A1 in T24R2 cells but not in T24 cells. Among Bcl-2 family members, Bfl-1/A1 showed the most significant alteration of the expression level in resistant cells. The nuclear translocation of nuclear factor-kappaB (NF-κB) by cisplatin and γ-irradiation selectively occurred in T24R2 cells. Mitochondrial depolarization and cell death by cisplatin were also prevented in T24R2 cells. Moreover, Bfl-1/A1 inhibited cisplatin- and TNF-α-induced apoptosis in BOSC23 cells. Our findings suggest that the induction of Bfl-1/A1 by NF-κB may be important in controlling resistance to cisplatin responses in bladder tumor cells. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.